Helius Story

<div class='circular--portrait' style='background:#82ADFD;color: #ffffff;font-size:4em;'>HM</div>
HSDT -- USA Stock  

USD 15.97  0.33  2.02%

In spite of comparatively uncertain basic indicators, Helius Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. The company current chance of financial distress is under 1 percent. Will private investors continue to be optimistic, or should we expect a sell-off?
Published over two weeks ago
View all stories for Helius Medical | View All Stories
Does Helius Medical (NASDAQ:HSDT) have stable basic indicators based on the newest gain?
Helius Medical holds a performance score of 9 on a scale of zero to a hundred. The company retains a Market Volatility (i.e. Beta) of -0.5198, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Helius's beta means in this case. As returns on the market increase, returns on owning Helius Medical are expected to decrease at a much lower rate. During the bear market, Helius Medical is likely to outperform the market. Although it is essential to pay attention to Helius Medical Techn current price history, it is also good to be reasonable about what you can do with equity current price movements. Our philosophy towards determining future potential of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if Helius Medical Techn expected return of 17.15 will be sustainable into the future, we have found twenty-eight different technical indicators, which can help you to check if the expected returns are sustainable. Use Helius Medical semi variance, and the relationship between the treynor ratio and daily balance of power to analyze future returns on Helius Medical.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Helius Medical income statement, its balance sheet, and the statement of cash flows. Potential Helius Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Helius Medical investors may use each financial statement separately, they are all related. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Helius Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages. The goal of Helius Medical fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Helius Medical performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Helius Medical shares is the value that is considered the true value of the share. If the intrinsic value Helius is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Helius Medical. Please read more on our fundamental analysis page.

What is Helius Asset Breakdown?

Helius Medical reports assets on its Balance Sheet. It represents the amount of Helius resources that either has an existing economic value or will provide some form of benefits in the future. To get a better handle on how balance sheet or income statements item affect Helius volatility, please check the breakdown of all its fundamentals

How Helius utilizes its cash?

To perform a cash flow analysis of Helius Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Helius Medical is receiving and how much cash it distributes out in a given period. The Helius Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Helius Medical Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Helius Medical reported Net Cash Flow from Operations of (18.9 Million) in 2020

Helius Medical Gross Profit

Helius Medical Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Helius Medical previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Helius Medical Gross Profit growth over the last 10 years. Please check Gross Profit in more details.

Detailed Outlook On Helius Medical

The newest price gain of Helius Medical may raise some interest from private investors. The stock closed today at a share price of 18.35 on 2,344,251 in trading volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in February. The stock standard deviation of daily returns for 30 days investing horizon is currently 127.18. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Helius Medical partners.

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Helius Medical has an asset utilization ratio of 9.14 percent. This implies that the company is making $0.0914 for each dollar of assets. An increasing asset utilization means that Helius Medical is more efficient with each dollar of assets it utilizes for everyday operations.

Current Assets
8.9 M
Assets Non Current
3.9 M
Current Assets8.86 Million61.76
Assets Non Current3.85 Million26.87
Goodwill1.63 Million11.38

Our take on today Helius Medical gain

Newest skewness indicator falls down to -0.26. Possible price appreciation? Helius Medical shows above-average downside volatility for the selected time horizon. We advise investors to inspect Helius Medical further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Helius Medical future alpha.

Our Conclusion on Helius Medical

Whereas some companies under the medical devices industry are still a bit expensive, Helius Medical may offer a potential longer-term growth to private investors. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to sell some or all of your Helius Medical holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Helius Medical.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Helius Medical. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com